lumevoq

GenSight Biologics’ LUMEVOQ, is a treatment for leber hereditary optic neuropathy (LHON), a common mitochondrial disease. Brandsymbol was engaged to create a compelling brand identity to communicate the benefits of this new compound. Our final design successfully communicates both the technological and humanistic aspects of LUMEVOQ. With a design that represents an eye combined with a customized typeface featuring sharp angles, the visual identity exudes technical excellence balanced with a color palette that evokes empathy for those battling LHON.